Logging Multiple Compounds Without Mixing Up the Record

Tracking more than one compound goes wrong in three places: names that shrink into shorthand, unit counts that look identical across vials of different strength, and entries that lump several injections into one row. Fix all three with full spelled-out names, one entry per compound per administration, and a vial reference on every entry.

The underlying problem is that a syringe reading tells you liquid volume. Once two vials of different strength are in use, volume alone no longer identifies the dose.

Where the ambiguity comes from

Each source leaves a different mark in a log, and each has a mechanical fix.

The Institute for Safe Medication Practices publishes its list of error-prone abbreviations because condensed notation gets misread even in clinical settings by trained staff. A private shorthand invented for speed has none of that scrutiny, and you will be the one misreading it.

Give every vial its own identity

A vial is the unit of tracking, and each dose entry needs to point at one. The compound name alone is not enough, because the same compound can be in two vials at different concentrations, different ages, and different remaining volumes.

A workable identity has four parts: the compound name, a short number or letter, the concentration, and the first-puncture date. Written out: "vial 3, 2.5 mg/mL, opened Aug 4." Put the same string on a physical label. Never reuse a vial number while the old vial still exists, even empty and waiting for disposal. The vial inventory guide covers the fields in full.

One entry per compound, every time

Each injection gets its own entry. This preserves your ability to connect anything you observe to a specific compound at a specific dose.

A combined entry that reads "morning doses given" collapses information you cannot recover. Two separate entries, each with compound, vial, concentration, volume, milligrams, site, and time, let you filter to one compound later and read its whole timeline.

If you give several injections in one session, record the order as well. It lets you match a local reaction to the right site and the right compound.

Look-alike vials

Similar names cause errors, which is why look-alike and sound-alike naming is a standing concern in medication safety. In a home setting the risk is larger, because the vials are often visually identical, from the same supplier, in the same box.

Physical differences do most of the work.

• A different colored label per compound, applied when you mix.
• A fixed storage position for each compound.
• Vial numbers that do not overlap between compounds, so "vial 3" means one thing.
• Full names on every label, with any distinguishing detail written out.
• A quick read of the label immediately before you draw.

The read-back step feels excessive until the first time it catches you reaching for the wrong vial half awake.

Do not combine compounds in one syringe

Putting two products in one syringe is a compounding decision. Compatibility, stability, and sterility all come into play, and USP General Chapter <797> treats manipulations of sterile preparations as controlled operations for those reasons. Ask a pharmacist.

The record-keeping argument points the same way. A combined injection has one site, one time, and two compounds, so any local reaction cannot be attributed and any change in effect has two candidate causes. Separate injections cost thirty seconds and keep the ability to reason about what happened.

The same logic rules out sharing a syringe or needle between vials. Beyond the sterility issue, carryover contaminates both vials and invalidates the concentration you recorded.

A labeled blend, where several peptides arrive already combined in one vial, is a different case. It is one vial, one draw, one entry. Record the draw and the amount of each component. The peptide blend math guide shows how to work out each component's share.

Rotate sites across all compounds

Rotation has to be global, not per compound. Tissue responds to the number of punctures it receives, and it makes no distinction based on what was injected.

If you keep a numbered site map, advance through it for every injection regardless of compound. Two compounds injected in one session take the next two positions in the sequence, not the same position on opposite sides. Recording the site on each entry is what makes this checkable later, and it is the field most likely to be skipped when there are several injections to get through. The site rotation guide has the grid.

Structure beats freeform

Freeform notes decay. Within a few weeks, typed compound names have three spellings, concentrations appear inconsistently, and the log can no longer be filtered.

Structure means the compound and vial are selectable records rather than text fields, the concentration lives on the vial and is never retyped per dose, milligrams are computed from volume and concentration rather than typed, and you can view one compound's timeline at a time as well as the combined view. Vitadel Protocol models each compound with its own vial, schedule, and dose history for that reason, so adding a second or third compound does not degrade the log.

What a reviewer should be able to see

Assume a clinician will read this with limited time. Without asking you anything, they should be able to answer: which compounds, at what dose in milligrams, at what interval, from which preparation, and where the injections have been going.

That means an export that lists each compound separately in date order, with units and milligrams both present, concentrations stated, sites included, and gaps marked as skips rather than left blank. A log that needs you in the room to be interpreted is not finished.